| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $109.8M | -3.7% |
| SG&A Expense | $33.2M | +15.1% |
| Operating Income | -$143.0M | -0.1% |
| Income Tax | $0 | — |
| Net Income | -$129.5M | -1.3% |
| EPS (Basic) | -$1.47 | +19.7% |
| EPS (Diluted) | -$1.47 | +19.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $45.7M | -23.1% |
| Current Assets | $288.5M | +10.0% |
| Total Assets | $408.9M | +49.2% |
| Current Liabilities | $20.4M | -17.8% |
| Total Liabilities | $24.5M | -20.9% |
| Stockholders' Equity | $384.4M | +58.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$111.0M | +1.5% |
| Capital Expenditures | $712K | -40.1% |
| Investing Cash Flow | -$148.0M | -768.7% |
| Financing Cash Flow | $245.3M | +93.8% |
| Free Cash Flow | -$111.7M | +1.9% |